Get started
Author

Omar Alzayat

Observed name: Alzayat, Omar
ORCID: 0009-0004-0925-7555
Observed ORCID: 0009-0004-0925-7555
OpenAlex ID: A5065715792
FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders
2022 · Austin Lui, Jordan Vanleuven, et al. · Pharmaceuticals · 36
PDF
Tumor Suppressor MicroRNAs in Clinical and Preclinical Trials for Neurological Disorders
2024 · Austin Lui, Timothy Do, et al. · Pharmaceuticals · 9
PDF
Multi-targeted anti-inflammatory drugs for the treatment of neurological disorders
2022 · Austin Lui, Omar Alzayat, et al. · Neural Regeneration Research · 3
GRAPPA 2024 Meeting: Advances in Psoriatic Disease Research From Pilot Grant Awardees
2025 · Keith Colaco, Omar Alzayat, et al. · The Journal of Rheumatology
Vaccine Beliefs Among Uninsured People Receiving Care at Free Clinics
2024 · Caroline C. Liu, Julio A. Siliezar, et al. · Journal of Community Health
PDF
Works count: 6
Citation count: 48
H-index: 3
I10-index: 1
Year
Topic
Type